Research Correspondence

DOI: 10.4244/EIJ-D-24-00911

Optical coherence tomography versus intravascular ultrasound- guided PCI in patients with and without acute coronary syndrome: a prespecified subanalysis of the OCTIVUS trial

Ju Hyeon Kim1,2, MD, PhD; Soon Jun Hong1, MD, PhD; Subin Lim1, MD, PhD; Jung-Joon Cha1, MD, PhD; Hyung Joon Joo1, MD, PhD; Jae Hyoung Park1, MD, PhD; Cheol Woong Yu1, MD, PhD; Do-Sun Lim1, MD, PhD; Do‐Yoon Kang2, MD, PhD; Jung‐Min Ahn2, MD, PhD; Duk‐Woo Park2, MD, PhD; Seung‐Jung Park2, MD, PhD

The latest European guidelines recommend intracoronary imaging (ICI) guidance by intravascular ultrasound (IVUS) or optical coherence tomography (OCT) for percutaneous coronary intervention (PCI) on anatomically complex lesions, particularly for left main stem, true bifurcations, and long lesions1. However, large-scale randomised studies comparing the efficacy between ICI-guided and angiography-guided PCI in patients with acute coronary syndrome (ACS) remain limited. In patients with non-ST-segment elevation ACS, OCT-guided PCI has been associated with a higher post-PCI fractional flow reserve compared to angiography guidance, providing detailed information on lesion characteristics and stent expansion2. Performing OCT-guided PCI in acute settings poses significant challenges due to the need for blood clearance, which may lead to complications such as slow flow, dissection, and distal embolisation3. We investigated whether OCT offers comparable clinical efficacy and safety to IVUS for patients with and without ACS in an all-comers PCI population.

In this post hoc analysis of the OCTIVUS trial with extended 2-year follow-up, we evaluated the outcomes of OCT versus IVUS guidance for PCI in ACS and non-ACS patients, building upon the initial 1-year non-inferiority findings4....

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 10
May 16, 2025
Volume 21 Number 10
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
Trending articles
95.45

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
61.2

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved